IPP Bureau
MGM Hospitals deliver life-saving CAR-T therapy to elderly cancer patients in Chennai
By IPP Bureau - March 05, 2026
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Rapid medical weight loss fuels surge in facial aesthetics, Allergan data shows
By IPP Bureau - March 05, 2026
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
Theravance Biopharma winds down Ampreloxetine programme after Phase 3 miss
By IPP Bureau - March 05, 2026
Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy
By IPP Bureau - March 05, 2026
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
Glenmark bags FDA nod for generic asthma inhaler with 180-day exclusivity
By IPP Bureau - March 05, 2026
Merck’s KEYTRUDA & WELIREG combo shows breakthrough results in kidney cancer trial
By IPP Bureau - March 03, 2026
Merck emphasized the broader significance of the findings
AbbVie’s Risankizumab shows strong results in hard-to-treat Crohn’s disease patients
By IPP Bureau - March 03, 2026
This study evaluated a difficult-to-treat Crohn's disease patient population
Bioxytran reports 90% day-5 viral clearance in COVID-19 trial at highest dose of ProLectin-M
By IPP Bureau - March 03, 2026
Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile
Medi Assist teams up with LawtonAsia to bring AI-powered health-tech to Southeast Asia
By IPP Bureau - March 03, 2026
The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
Dabur backs luxury skincare startup RAS Beauty with Rs 60 crore investment
By IPP Bureau - March 03, 2026
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
FDA nod to YUVIWEL, first once-weekly treatment for kids with achondroplasia
By IPP Bureau - March 03, 2026
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
Caplin Steriles gets FDA approval for desmopressin
By IPP Bureau - March 02, 2026
Desmopressin Acetate Injection is primarily used to treat central diabetes insipidus, haemophilia A, and von Willebrand disease
Zydus receives final approvals from USFDA for Ivermectin Tablets USP
By IPP Bureau - March 02, 2026
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
